Search

Your search keyword '"Konishi, Masaru"' showing total 931 results
Start Over Author "Konishi, Masaru"
931 results on '"Konishi, Masaru"'

4. Relationship of oral bacterial number with medical hospitalization costs in analysis of Diagnosis Procedure Combination database from single institution in Japan

Author

Nishi, Hiromi, Kajiya, Mikihito, Ohta, Kouji, Shigeishi, Hideo, Obayashi, Taiji, Munenaga, Syuichi, Obayashi, Nami, Yoshioka, Yukio, Konishi, Masaru, Naruse, Takako, Matsumoto, Akihiro, Odo, Ayaka, Kitagawa, Masae, Ando, Toshinori, Shintani, Tomoaki, Tokikazu, Tomoko, Ino, Natsumi, Mihara, Naoki, Kakimoto, Naoya, Tsuga, Kazuhiro, Tanimoto, Kotaro, Ohge, Hiroki, Kurihara, Hidemi, and Kawaguchi, Hiroyuki

Published
2024
Full Text
View/download PDF

8. Head and neck cancer patients show poor oral health as compared to those with other types of cancer

Author

Nishi, Hiromi, Obayashi, Taiji, Ueda, Tsutomu, Ohta, Kouji, Shigeishi, Hideo, Munenaga, Syuichi, Kono, Takashi, Yoshioka, Yukio, Konishi, Masaru, Taga, Ryotaro, Toigawa, Yuya, Naruse, Takako, Ishida, Eri, Tsuboi, Eri, Oda, Kanae, Dainobu, Kana, Tokikazu, Tomoko, Tanimoto, Kotaro, Kakimoto, Naoya, Ohge, Hiroki, Kurihara, Hidemi, and Kawaguchi, Hiroyuki

Published
2023
Full Text
View/download PDF

11. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202

Author

Kobayashi, Shogo, Nakachi, Kohei, Ikeda, Masafumi, Konishi, Masaru, Ogawa, Gakuto, Sugiura, Teiichi, Yanagimoto, Hiroaki, Morinaga, Soichiro, Wada, Hiroshi, Shimada, Kazuaki, Takahashi, Yu, Nakagohri, Toshio, Kamata, Ken, Shimizu, Yasuhiro, Ajiki, Tetsuo, Hirano, Satoshi, Gotohda, Naoto, Ueno, Makoto, Okusaka, Takuji, and Furuse, Junji

Published
2024
Full Text
View/download PDF

15. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Author

Okamura, Keiya, Kawamoto, Yasuyuki, Katanuma, Akio, Unno, Michiaki, Shirakawa, Hirofumi, Yamaguchi, Hironori, Takahashi, Amane, Ikeda, Masafumi, Yanagibashi, Hiroo, Kato, Naoya, Okusaka, Takuji, Sakamoto, Yoshihiro, Kojima, Yasushi, Higuchi, Ryota, Sasahira, Naoki, Sano, Keiji, Nakagohri, Toshio, Sunakawa, Yu, Morinaga, Soichiro, Kumamoto, Yusuke, Sugimori, Kazuya, Nomura, Tatsuya, Shibuya, Kazuto, Makino, Isamu, Yamazaki, Kentaro, Mizuno, Nobumasa, Kamata, Ken, Wada, Hiroshi, Gotoh, Kunihito, Sekimoto, Mitsugu, Ajiki, Tetsuo, Nakamura, Ikuo, Miki, Ikuya, Nagano, Hiroaki, Ohta, Koji, Okabayashi, Takehiro, Furukawa, Masayuki, Fujimori, Nao, Nakachi, Kohei, Konishi, Masaru, Nomura, Shogo, Katayama, Hiroshi, Kataoka, Tomoko, Todaka, Akiko, Yanagimoto, Hiroaki, Kobayashi, Shogo, Shimada, Kazuaki, Takahashi, Yu, Shimizu, Yasuhiro, Ueno, Makoto, Ishii, Hiroshi, and Furuse, Junji

Published
2023
Full Text
View/download PDF

23. Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-label Multicenter Prospective Trial (JASPAC05)

Author

Takahashi, Shinichiro, Ohno, Izumi, Ikeda, Masafumi, Konishi, Masaru, Kobayashi, Tatsushi, Akimoto, Tetsuo, Kojima, Motohiro, Morinaga, Soichiro, Toyama, Hirochika, Shimizu, Yasuhiro, Miyamoto, Atsushi, Tomikawa, Moriaki, Takakura, Norihisa, Takayama, Wataru, Hirano, Satoshi, Otsubo, Takehito, Nagino, Masato, Kimura, Wataru, Sugimachi, Keishi, and Uesaka, Katsuhiko

Published
2022
Full Text
View/download PDF

24. Radiation doses of medical radiation workers performing low-dose-rate brachytherapy with 198Au grains and 192Ir pins for patients with oral cancers.

Author

Konishi, Masaru, Shimabukuro, Kiichi, Hirokawa, Junichi, Sadatoki, Takashi, Katsuta, Tsuyoshi, Imano, Nobuki, Nishibuchi, Ikuno, Murakami, Yuji, and Kakimoto, Naoya

Subjects
MOUTH tumors, FISHER exact test, RADIOISOTOPE brachytherapy, RADIATION dosimetry, CANCER patients, DESCRIPTIVE statistics, CHI-squared test, MANN Whitney U Test, ALLIED health personnel, DENTISTS, MEDICAL radiology, RADIATION doses, PHYSICIANS, TONGUE tumors, DATA analysis software
Abstract

Objectives: Low-dose-rate brachytherapy (LDR-BT) with 198Au grains and 192Ir pins is an essential treatment option for oral cancer due to its high rate of local control and low invasiveness. However, the radiation exposure of medical radiation workers is concerning. Thus, we aimed to determine the radiation dose delivered to medical radiation workers during LDR-BT using 198Au grains and 192Ir pins for oral cancer. Methods: Thirty-two patients with oral cancer underwent 198Au grain interstitial LDR-BT between June 2016 and May 2023, and 23 patients with tongue cancer underwent 192Ir pin interstitial LDR-BT between March 2015 and November 2017 at our hospital. Dosimetry was performed by attaching a dosimeter to the chest pocket of the operator and assistant during 198Au grain or 192Ir pin LDR-BT. Since the operator also loads 198Au grains into the implantation device, the operator's radiation dose includes the dose received during this preparation. Results: Mean radiation doses of the operators with 198Au grain and 192Ir pin LDR-BT were 165.8 and 211.2 μSv, respectively. Statistically significant differences between the radioactive sources of 198Au grain and 192Ir pin LDR-BT were observed (p = 0.0459). The mean radiation doses of the assistants with 198Au grain and 192Ir pin LDR-BT were 92.0 and 162.0 μSv, respectively. Statistically significant differences were observed between the radioactive sources of 198Au grains and 192Ir pin LDR-BT (p = 0.0003). Conclusions: Regarding radioactive source differences, 192Ir pin LDR-BT resulted in higher doses delivered to medical radiation workers than 198Au grain LDR-BT. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study

Author

Nishi, Hiromi, primary, Horikoshi, Susumu, additional, Ohta, Kouji, additional, Yoshida, Tetsumi, additional, Fukushima, Noriyasu, additional, Oshita, Kyoko, additional, Munenaga, Syuichi, additional, Edahiro, Taro, additional, Ureshino, Hiroshi, additional, Shigeishi, Hideo, additional, Yoshioka, Yukio, additional, Konishi, Masaru, additional, Ide, Noriaki, additional, Ogawa, Yuma, additional, Marukawa, Rikou, additional, Shintani, Tomoaki, additional, Ino, Natumi, additional, Kajiya, Mikihito, additional, Kakimoto, Naoya, additional, Ohge, Hiroki, additional, Ichinohe, Tatsuo, additional, and Kawaguchi, Hiroyuki, additional

Published
2023
Full Text
View/download PDF

28. Can oral diadochokinesis be used as an assessment tool of oral function in older adults requiring care in nursing home?

Author

Konishi, Masaru

Subjects
*MOUTH physiology, *STATISTICS, *CHEEK, *MULTIVARIATE analysis, *GERIATRIC assessment, *TONGUE, *COGNITION, *ACTIVITIES of daily living, *NURSING care facilities, *ORAL disease diagnosis, *VERBAL behavior testing, *BODY movement, *DEMENTIA, *ELDER care, *ARTICULATION (Speech), *LIPS, *OLD age
Abstract

Background: Oral diadochokinesis (OD) test is an articulation test that analyses fine movements of the lips, cheeks and tongue. It is difficult to perform the test accurately in older people with reduced physical and cognitive functions. Objectives: This study aimed to investigate the number of older adults who could not be tested for OD and to investigate their characteristics. Methods: The participants included 145 older residents of an aged care nursing home. They were divided into two groups: those who could be tested for OD and those who could not, and their characteristics were compared. The degree of requiring long‐term care was classified into five levels. The degree of dementia was classified into five levels. Those having difficulty in performing daily activities alone and having degree III or higher dementia were considered to have severe dementia. Results: The participants included 41 men and 104 women with a median age of 89 years (range, 64–105 years). Sixty‐eight participants failed the OD test (46.9%). In univariate and multivariate analyses, degree of dementia and oral care (among other characteristics in univariate analysis) showed statistically significant differences between the two groups. Cut‐off values for older adults who could not perform OD test were level 4 or higher in need of care and degree III or higher in dementia. Conclusion: This study suggests that additional assessment tools for oral function should be considered for older adults requiring a nursing care level of 4 or higher and a dementia degree of III or higher. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Subjective and objective assessments of sweet, umami, and bitter tastes after brachytherapy for patients with tongue cancer.

Author

Konishi, Masaru, Shimabukuro, Kiichi, and Kakimoto, Naoya

Abstract

Aim: The aim of this study is to investigate subjective symptoms and expression of receptors for sweet, umami, and bitter tastes after brachytherapy in patients with tongue cancer. Methods: Post‐brachytherapy changes in taste were investigated both subjectively (visual analog scale [VAS] score) and objectively (expression of taste receptors) through 37 examinations on 10 patients who received brachytherapy for treatment of tongue cancer at our hospital. The VAS was scored on a scale of 0–100. A VAS score of ≥90 was considered to indicate restoration of taste. For taste receptor expression, taste cells were collected from the brachytherapy (BRT) and non‐brachytherapy (non‐BRT) sides of the tongue, which were separated in the middle of the dorsum of the tongue, and evaluated by the ratio of the expression level of one side to the other. The mRNA expression levels of taste receptors were classified into three groups according to the number of days after BRT: ≤99, 100–299, and ≥300 days. Results: The number of days to a post‐brachytherapy VAS score of 90 or more was 284, 308, and 308 days for sweet, umami, and bitter tastes, respectively. Taste receptor expression was compared in three groups by number of days after radiotherapy: ≤99, 100–299, and ≥300, and no statistically significant differences were found among the tastes. Conclusion: The VAS scores showed that these tastes recovered approximately 300 days after brachytherapy. The ratio of taste receptor expression levels varied widely, and no specific indications of changes in taste receptor expression over time were obtained. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05)

Author

Takahashi, Shinichiro, Ohno, Izumi, Ikeda, Masafumi, Konishi, Masaru, Kobayashi, Tatsushi, Akimoto, Tetsuo, Kojima, Motohiro, Morinaga, Soichiro, Toyama, Hirochika, Shimizu, Yasuhiro, Miyamoto, Atsushi, Tomikawa, Moriaki, Takakura, Norihisa, Takayama, Wataru, Hirano, Satoshi, Otsubo, Takehito, Nagino, Masato, Kimura, Wataru, Sugimachi, Keishi, and Uesaka, Katsuhiko

Published
2020
Full Text
View/download PDF

36. Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)

Author

Hagiwara, Yasuhiro, Ohashi, Yasuo, Uesaka, Katsuhiko, Boku, Narikazu, Fukutomi, Akira, Okamura, Yukiyasu, Konishi, Masaru, Matsumoto, Ippei, Kaneoka, Yuji, Shimizu, Yasuhiro, Nakamori, Shoji, Sakamoto, Hirohiko, Morinaga, Soichiro, Kainuma, Osamu, Imai, Koji, Sata, Naohiro, Hishinuma, Shoichi, Ojima, Hitoshi, Yamaguchi, Ryuzo, Hirano, Satoshi, and Sudo, Takeshi

Published
2018
Full Text
View/download PDF

41. Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer

Author

Yasuta, Sho, Kobayashi, Tatsushi, Aizawa, Hidetoshi, Takahashi, Shinichiro, Ikeda, Masafumi, Konishi, Masaru, Kojima, Motohiro, Kuno, Hirofumi, Uesaka, Katsuhiko, Morinaga, Soichiro, Miyamoto, Atsushi, Toyama, Hirochika, Takakura, Norihisa, Sugimachi, Keishi, and Takayama, Wataru

Published
2020
Full Text
View/download PDF

43. Effectiveness of Spacers in Brachytherapy With198Au Grains for Patients With Buccal Mucosa Cancer

Author

KONISHI, MASARU, primary, HIROKAWA, JUNICHI, additional, MIYOSHI, SHOTA, additional, KATSUTA, TSUYOSHI, additional, IMANO, NOBUKI, additional, NISHIBUCHI, IKUNO, additional, MURAKAMI, YUJI, additional, SHIMABUKURO, KIICHI, additional, NAKASHIMA, TAKEO, additional, TAKEUCHI, YUKI, additional, KAKIMOTO, NAOYA, additional, and NAGATA, YASUSHI, additional

Published
2023
Full Text
View/download PDF

48. Supplementary Figure 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure Legend from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results